A mismatch between the clinical indication in the operative note and the diagnosis code on the claim is a common denial trigger for CPT 28760
Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
Unfortunately, there is no one rule that says a human can only have one cause or one etiology to their problem. Dr
Drugs losing patent protection in the next five years Over the next five years, several high-profile drugs are expected to lose patent protection
PDP does not provide stacking recommendations involving SLU-PP-332